National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Plague
 Forms of Plague
 Transmission
 Diagnosis
 Treatment
 Prevention
 Research


Plague

Evolution of Plague: Two Distinct Transmission Routes Described

Over millennia of evolution, Yersinia pestis—the bacterial agent of plague—has acquired an enzyme enabling it to attack the lymph system, thus allowing the development of the bubonic form of plague infection.

But this wasn’t the first type of recognized infection caused by Y. pestis, say scientists at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, MT. By studying an enzyme known as a plasminogen activator, or Pla, a research group led by B. Joseph Hinnebusch, Ph.D., answered a longstanding question about the origin of the other main type of plague, septicemic plague. Researchers had previously thought that septicemia always followed a lymph system infection rather than direct infection of the bloodstream.

In studies involving laboratory mice, RML scientists used natural flea-borne transmission of Y. pestis to infect the animals. The group used both a common Y. pestis strain found in nature and a mutant strain wherein the Pla was removed.

Of ten mice exposed to the mutant strain by flea bite, three developed septicemic plague while none developed bubonic plague. Of 10 mice exposed to the natural strain by flea bite, eight developed plague, six the bubonic type and two the septicemic type. The results identified primary septicemic plague as a distinct form of the disease.

The researchers hypothesize that the Pla activity has a role in making human lymph systems vulnerable to Y. pestis infection, but is not required if fleas inject bacteria directly into the bloodstream.

Information about this work is available in the April 4, 2006, edition of Proceedings of the National Academy of Sciences.

Reference

Sebbane, F. et al. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. PNAS DOI: 10.1073/pnas.0509544103 (2006).

back to top


See Also

  • Rocky Mountain Laboratories
  • Laboratory of B. Joseph Hinnebusch, Ph.D.
  • New Insights Into the Virulence of Plague
  • E-mail Icon E-mail this page
    Print Icon Print this page

    See Also

  • Rocky Mountain Laboratories
  • Laboratory of B. Joseph Hinnebusch, Ph.D.
  • New Insights Into the Virulence of Plague